Mild hidradenitis suppurativa is often treated with cycles of steroids and antibiotics that have adverse effects. Can an anti ...

In both trials, envudeucitinib showed greater skin clearance than placebo on both co-primary endpoints at week 16.

Credit: Getty Images. The sNDA is supported by data from the multicenter, double-blind, placebo-controlled phase 3 ADVANCE trial. The Food and Drug Administration (FDA) has accepted for review the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PASI 75 responses among patients treated with AX-158 ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

The FDA has approved the first topical novel therapy for psoriasis in 25 years, Roivant Sciences announced. Tapinarof cream 1% (Vtama) received an indication for mild, moderate, and severe plaque ...

Reader's DigestHome Remedies for Eczema and Psoriasis ReliefSave money on expensive skin care treatments and try these homemade remedies first. Plaque psoriasis is a skin disease that causes raised ...

(RTTNews) - Amgen (AMGN) said that it has submitted a supplemental New Drug Application or sNDA to the U.S. Food and Drug Administration for Otezla or apremilast for the treatment of adults with ...

Please provide your email address to receive an email when new articles are posted on . Overall psoriasis severity and scalp psoriasis, as well as itch and quality of life, were improved in patients ...

Biotech stock Alumis catapulted on Tuesday after the company unveiled promising results that could help it compete against ...

Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...